This federal contract award is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,921.68, is a firm fixed-price delivery order awarded to the prime contractor, Amerisourcebergen Drug Corp. The contract has an ultimate completion date of October 10, 2024 and is not designated under any set-aside program. Amerisourcebergen Drug Corp, as one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts by various defense and civilian agencies to supply a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, medical supplies, and equipment to support military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation for delivering these critical medical products and pharmaceuticals.
Generated 1/8/25, 9:30 AM